Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane in Advanced Transitional Cell Carcinoma of the Urothelium
NCT00683059Phase 2Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Mar 2008
- Primary completion
- Jun 2012
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in transitional cell carcinoma (TCC), sponsored by Sunnybrook Health Sciences Centre. Started Mar 2008; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT00683059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683059.